A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Optimization of Transcardiac Perfusion for More Accurately Evaluating Biodistribution of Large Molecules. | LitMetric

Optimization of Transcardiac Perfusion for More Accurately Evaluating Biodistribution of Large Molecules.

Int J Mol Sci

Drug Metabolism and Pharmacokinetics, Biogen, Cambridge, MA 02142, USA.

Published: November 2024

The accurate assessment of drug concentrations in biodistribution studies is crucial for evaluating the efficacy and toxicity of compounds in drug development. As the concentration of biologics in plasma can be higher than in tissue due to their potentially low volume of distribution, transcardiac perfusion is commonly employed to reduce the influence of excess drugs in residual blood. However, there is a lack of consistency in the literature on the conditions and methods of perfusion. To enhance blood removal during transcardiac perfusion, sodium nitrite (NaNO), a vasodilator, has been widely used with concentrations up to 5% in publications. However, we found that such high NaNO could disrupt the BBB during perfusion, which should be avoided in experiments. In this study, we examined the impact of various vasodilators on blood-brain barrier integrity and vascular permeability using the ratio of FITC-Dextran to Texas Red-Dextran (FITC/Texas Red). Additionally, we optimized perfusion conditions-including euthanasia method and perfusion flow rate-based on hemoglobin levels and the FITC/Texas Red ratio in tissues. Despite the superiority of NaNO in terms of solubility and cost over other vasodilators, we found that 2% NaNO disrupted blood-brain barrier integrity, significantly altering the FITC/Texas Red ratio. In contrast, 100 mM NaNO did not significantly affect this ratio. Moreover, under Ketamine/Xylazine (Ket/Xyl) anesthesia, which reduced blood clot formation compared to CO euthanasia, 100 mM NaNO achieved the lowest hemoglobin levels in the brain. Compared to other vasodilators and the PBS control group, 100 mM NaNO decreased the tissue/plasma ratio (K) but not brain/plasma ratio (K) of hIgG1 and human transferrin. We have developed a method to efficiently evaluate blood-brain barrier integrity during transcardiac perfusion. The combination of Ket/Xyl anesthesia and 100 mM NaNO effectively removes residual blood from tissues without significantly affecting blood vessel permeability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11594646PMC
http://dx.doi.org/10.3390/ijms252212180DOI Listing

Publication Analysis

Top Keywords

transcardiac perfusion
16
100 nano
16
blood-brain barrier
12
barrier integrity
12
fitc/texas red
12
perfusion
8
residual blood
8
nano
8
hemoglobin levels
8
red ratio
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!